We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Black Diamond Therapeutics Inc | NASDAQ:BDTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.03 | 0.68% | 4.47 | 4.23 | 12.63 | 4.49 | 4.25 | 4.45 | 500,026 | 05:00:08 |
Delaware | 001-39200 | 81-4254660 | ||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trade Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, $0.0001 par value per share | BDTX | The Nasdaq Global Select Market |
Exhibit No. | Description | |||||||
Black Diamond Therapeutics, Inc. | ||||||||
Date: May 9, 2023 | By: | /s/ Brent Hatzis-Schoch | ||||||
Brent Hatzis-Schoch | ||||||||
Chief Operating Officer and General Counsel |
1 Year Black Diamond Therapeutics Chart |
1 Month Black Diamond Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions